141 related articles for article (PubMed ID: 6194253)
1. Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients.
Vilde JL; Bricaire F; Huchon A; Brun-Vezinet F
J Med Virol; 1983; 12(2):149-53. PubMed ID: 6194253
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary clinical experiences with adenine arabinoside monophosphate (ARA-AMP) in encephalitis due to viruses of the herpes group and varicella/zoster infections (author's transl)].
Sauer O; Werner GT; Schneider H; Lenard HG; von Haselberg L; Nettesheim HJ
Klin Padiatr; 1979 Nov; 191(6):566-71. PubMed ID: 92592
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary animal experimental results and clinical experiences with the antiviral agent adenine arabinoside monophosphate in encephalitis from herpes group and varicella-zoster infections].
Sauer O; Huth E; Lenard HG; Schneider H; von Haselberg L; Nettesheim HJ; Werner GT
Monatsschr Kinderheilkd (1902); 1980 May; 128(5):248-50. PubMed ID: 6158680
[No Abstract] [Full Text] [Related]
4. Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.
Soike KF; Felsenfeld AD; Gibson S; Gerone PJ
Antimicrob Agents Chemother; 1980 Jul; 18(1):142-7. PubMed ID: 6158291
[TBL] [Abstract][Full Text] [Related]
5. [Adenine arabinoside treatment of varicella and generalized herpes zoster in 43 immunosuppressed patients].
Vildé JL; Bricaire F; Huchon A; Dournon E; Brun-Vezinet F; Leport C; Bastin R
Nouv Presse Med; 1982 Nov; 11(48):3547-50. PubMed ID: 7155866
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
[TBL] [Abstract][Full Text] [Related]
7. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
Hoofnagle JH
J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
[TBL] [Abstract][Full Text] [Related]
8. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
[TBL] [Abstract][Full Text] [Related]
9. [The virostatic effect of adenine-arabinoside monophosphate. Experimental findings and preliminary clinical experiences].
Werner GT; Bömer H; Metzger E; Sauer O; Schneider H; Schubert E; Treuner J
Fortschr Med; 1978 Aug; 96(32):1589-97. PubMed ID: 680620
[TBL] [Abstract][Full Text] [Related]
10. Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients.
Vildé JL; Bricaire F; Leport C; Renaudie M; Brun-Vézinet F
J Med Virol; 1986 Oct; 20(2):127-34. PubMed ID: 3534140
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate.
Esteban R; Buti M; Vallés M; Allende H; Guardia J
Hepatology; 1986; 6(4):762-3. PubMed ID: 2426174
[No Abstract] [Full Text] [Related]
12. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
[TBL] [Abstract][Full Text] [Related]
13. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
[TBL] [Abstract][Full Text] [Related]
14. Treatment of varicella-zoster virus infections with adenine arabinoside.
Johnson MT; Buchanan RA; Luby JP; Mikulec D
J Infect Dis; 1975 Mar; 131(3):225-9. PubMed ID: 165242
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
[TBL] [Abstract][Full Text] [Related]
17. Iontophoretic application of adenine arabinoside monophosphate to herpes simplex virus type 1-infected hairless mouse skin.
Park NH; Gangarosa LP; Kwon BS; Hill JM
Antimicrob Agents Chemother; 1978 Oct; 14(4):605-8. PubMed ID: 82423
[TBL] [Abstract][Full Text] [Related]
18. Double blind trial in the treatment of herpes simplex and herpes zoster with adenine arabinoside and idoxuridine.
Theodoridis A; Sivenas C; Vagena A; Capetanakis J
Arch Dermatol Res; 1978 Jul; 262(2):173-6. PubMed ID: 356754
[TBL] [Abstract][Full Text] [Related]
19. Iontophoretic application of adenine arabinoside monophosphate for the treatment of herpes simplex virus type 2 skin infections in hairless mice.
Kwon BS; Hill JM; Wiggins C; Tuggle C
J Infect Dis; 1979 Dec; 140(6):1014. PubMed ID: 94335
[No Abstract] [Full Text] [Related]
20. Adenine arabinoside monophosphate in experimental vaccinia virus infections.
Werner GT; Metzger E; Sauer O
Adv Ophthalmol; 1979; 38():72-81. PubMed ID: 93408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
